American Society of Clinical Oncology

SHERPA: White

People

  1. Lichtman
    Lichtman
  2. Tew
    Tew
  3. Konner
    Konner
  4. Zhou
    Zhou
  5. Aghajanian
    Aghajanian
  6. Chi
    Chi
  7. Iasonos
    Iasonos
  8. O'Cearbhaill
    O'Cearbhaill
  9. Grisham
    Grisham
  10. Makker
    Makker

Groups

  1. Department of Medicine (63)
  2. Gynecologic Medicine Service (63)
  3. Solid Tumor Oncology Division (63)
  4. GDMT, Medicine (37)
  5. Gynecology Disease Management Team (37)
  6. Hematologic Malignancies, Division of (10)
  7. Survivorship Research (10)
  8. Epidemiology and Biostatistics (9)
  9. Population Sciences Research Program (9)
  10. Biostatistics Service (8)
Search Within
  1. "Stuart Lichtman"
Formats
  1. Meeting Abstract (36)
  2. Journal Article (26)
  3. Review (1)
Groups
  1. Department of Medicine (63)
  2. Gynecologic Medicine Service (63)
  3. Solid Tumor Oncology Division (63)
  4. GDMT, Medicine (37)
  5. Gynecology Disease Management Team (37)
  6. Hematologic Malignancies, Division of (10)

More Groups

People
  1. Stuart Lichtman (63)
  2. William Tew (33)
  3. Jason Konner (7)
  4. Qin Zhou (7)
  5. Alexia Iasonos (6)
  6. Carol Aghajanian (6)

More People

Years
  1. 2022 (2)
  2. 2021 (4)
  3. 2020 (2)
  4. 2019 (3)
  5. 2018 (2)
  6. 2017 (4)

More Years

Publications
  1. Journal of Clinical Oncology (58)
  2. Journal of Oncology Practice (3)
  3. American Society of Clinical Oncology Educational Book (2)

Results (63)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Characteristics of patients (pts) and prognostic factors across treatment lines (TL) in metastatic colorectal cancer (mCRC): An analysis from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
    Meeting Abstract

    Bachet, J. B.; Chibaudel, B.; Rakez, M.; Goldberg, R. M.; Tebbutt, N. C.; Van Cutsem, E.; Haller, D. G.; Hecht, J. R. R.; Mayer, R. J.; Lichtman, S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Use of the Delphi method to develop a guideline-based geriatric oncology gap assessment
    Meeting Abstract

    Plotkin, E.; Dale, W.; Loh, K. P.; Dotan, E.; Burhenn, P.; Presley, C. J.; Nightingale, G.; Oyer, R. A.; Ginex, P.; Karuturi, M. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study
    Journal Article

    Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • From assessment to implementation and beyond in cancer and aging research
    Review

    Lichtman, S. M.; Cohen, H. J.; Muss, H.; Tew, W. P.; Korc-Grodzicki, B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A randomized phase II trial of secondary cytoreductive surgery (SCS) plus /- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)
    Meeting Abstract

    Zivanovic, O.; Chi, D.; Zhou, Q.; Iasonos, A.; Makker, V.; Grisham, R. N.; Konner, J. A.; Diaz, J. P.; Brown, A. K.; Langstraat, C. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Receipt and survival outcomes by age following second-line therapy for metastatic CRC (mCRC): Analysis of 5,289 patients from the ARCAD Clinical Trials Program
    Meeting Abstract

    McCleary, N. J.; Harmsen, W. S.; VanCutsem, E.; Sobrero, A. F.; Goldberg, R. M.; Tabernero, J.; Seymour, M.; Saltz, L. B.; Giantonio, B. J.; Dirk, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Modeling accrual of older adults to cancer clinical trials: (Alliance A151736)
    Meeting Abstract

    VanderWalde, N. A.; Wakefield, D. V.; Satele, D. V.; Dockter, T.; Sloan, J. A.; Jagsi, R.; Lichtman, S. M.; Freedman, R. A.; Lafky, J. M.; Muss, H. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma
    Meeting Abstract

    Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save